{
  "disease_name": "Menkes disease",
  "orpha_code": "565",
  "drugs": [
    {
      "name": "Elesclomol-copper",
      "substance_url": "/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
      "substance_id": "661180",
      "regulatory_url": "/en/drug/regulatory/661273?name=565&mode=orpha&region=",
      "regulatory_id": "661273",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Elesclomol-copper(Medicinal product                        - 08/11/2023)Disease(s) concernedORPHA:565 Menkes disease",
        "Elesclomol-copper(Medicinal product                        - 08/11/2023)",
        "(Medicinal product                        - 08/11/2023)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
          "text": "Elesclomol-copper",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661273?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Copper nanocluster conjugated to acetate, histidinate and ascorbate",
      "substance_url": "/en/drug/substance/635863?name=565&mode=orpha&region=&status=all",
      "substance_id": "635863",
      "regulatory_url": "/en/drug/regulatory/635867?name=565&mode=orpha&region=",
      "regulatory_id": "635867",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Copper nanocluster conjugated to acetate, histidinate and ascorbate(Medicinal product                        - 11/11/2022)Disease(s) concernedORPHA:565 Menkes disease",
        "Copper nanocluster conjugated to acetate, histidinate and ascorbate(Medicinal product                        - 11/11/2022)",
        "(Medicinal product                        - 11/11/2022)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/635863?name=565&mode=orpha&region=&status=all",
          "text": "Copper nanocluster conjugated to acetate, histidinate and ascorbate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/635867?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Copper histidinate",
      "substance_url": "/en/drug/substance/604837?name=565&mode=orpha&region=&status=all",
      "substance_id": "604837",
      "regulatory_url": "/en/drug/regulatory/604838?name=565&mode=orpha&region=",
      "regulatory_id": "604838",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Copper histidinate(Medicinal product                        - 21/08/2020)Disease(s) concernedORPHA:565 Menkes disease",
        "Copper histidinate(Medicinal product                        - 21/08/2020)",
        "(Medicinal product                        - 21/08/2020)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604837?name=565&mode=orpha&region=&status=all",
          "text": "Copper histidinate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604838?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Elesclomol-copper",
      "substance_url": "/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
      "substance_id": "661180",
      "regulatory_url": "/en/drug/regulatory/689724?name=565&mode=orpha&region=",
      "regulatory_id": "689724",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Elesclomol-copper(Medicinal product                        - 30/10/2024)Disease(s) concernedORPHA:565 Menkes disease",
        "Elesclomol-copper(Medicinal product                        - 30/10/2024)",
        "(Medicinal product                        - 30/10/2024)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
          "text": "Elesclomol-copper",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689724?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant adeno-associated virus vector serotype-9 carrying the human ATP7A transgene",
      "substance_url": "/en/drug/substance/687224?name=565&mode=orpha&region=&status=all",
      "substance_id": "687224",
      "regulatory_url": "/en/drug/regulatory/687566?name=565&mode=orpha&region=",
      "regulatory_id": "687566",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Recombinant adeno-associated virus vector serotype-9 carrying the human ATP7A transgene(Medicinal product                        - 30/07/2024)Disease(s) concernedORPHA:565 Menkes disease",
        "Recombinant adeno-associated virus vector serotype-9 carrying the human ATP7A transgene(Medicinal product                        - 30/07/2024)",
        "(Medicinal product                        - 30/07/2024)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/687224?name=565&mode=orpha&region=&status=all",
          "text": "Recombinant adeno-associated virus vector serotype-9 carrying the human ATP7A transgene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687566?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Copper nanocluster conjugated to acetate, histidinate and ascorbate",
      "substance_url": "/en/drug/substance/635863?name=565&mode=orpha&region=&status=all",
      "substance_id": "635863",
      "regulatory_url": "/en/drug/regulatory/687484?name=565&mode=orpha&region=",
      "regulatory_id": "687484",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Copper nanocluster conjugated to acetate, histidinate and ascorbate(Medicinal product                        - 25/07/2024)Disease(s) concernedORPHA:565 Menkes disease",
        "Copper nanocluster conjugated to acetate, histidinate and ascorbate(Medicinal product                        - 25/07/2024)",
        "(Medicinal product                        - 25/07/2024)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/635863?name=565&mode=orpha&region=&status=all",
          "text": "Copper nanocluster conjugated to acetate, histidinate and ascorbate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687484?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Elesclomol-copper",
      "substance_url": "/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
      "substance_id": "661180",
      "regulatory_url": "/en/drug/regulatory/664214?name=565&mode=orpha&region=",
      "regulatory_id": "664214",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "Elesclomol-copper(Medicinal product                        - 03/08/2023)Disease(s) concernedORPHA:565 Menkes disease",
        "Elesclomol-copper(Medicinal product                        - 03/08/2023)",
        "(Medicinal product                        - 03/08/2023)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661180?name=565&mode=orpha&region=&status=all",
          "text": "Elesclomol-copper",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/664214?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "rsATP7A cDNA",
      "substance_url": "/en/drug/substance/399726?name=565&mode=orpha&region=&status=all",
      "substance_id": "399726",
      "regulatory_url": "/en/drug/regulatory/399743?name=565&mode=orpha&region=",
      "regulatory_id": "399743",
      "orpha_substance_code": "ORPHA:565",
      "details": [
        "rsATP7A cDNA(Medicinal product                        - 10/01/2014)Disease(s) concernedORPHA:565 Menkes disease",
        "rsATP7A cDNA(Medicinal product                        - 10/01/2014)",
        "(Medicinal product                        - 10/01/2014)",
        "Disease(s) concernedORPHA:565 Menkes disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/399726?name=565&mode=orpha&region=&status=all",
          "text": "rsATP7A cDNA",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565",
          "text": "ORPHA:565 Menkes disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/399743?name=565&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:53.287653",
  "run_number": 1,
  "total_drugs_found": 8,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Menkes+disease&orphaCode=565&name=565&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Menkes disease",
    "orphaCode": "565",
    "name": "565",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}